Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$697,937
in 4 filings, $698K under 10b5-1 plans

Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-12-02 Cooke Shane Director Grant or award · Restricted Stock Unit Award +5,578 5,578
2020-12-02 BREYER ROBERT A Director Grant or award · Non Qualified Stock Option (Right to Buy) +11,509 11,509
2020-12-02 BREYER ROBERT A Director Grant or award · Restricted Stock Unit Award +5,578 5,578
2020-12-02 ANSTICE DAVID W Director Grant or award · Non Qualified Stock Option (Right to Buy) +11,509 11,509
2020-12-02 ANSTICE DAVID W Director Grant or award · Restricted Stock Unit Award +5,578 5,578
2020-10-01 MITCHELL PAUL J Director Exercise or conversion +20,000 $14.92 $298K 27,000
2020-10-01 MITCHELL PAUL J Director Sale −20,000 $16.61 $332K 7,000
2020-10-01 MITCHELL PAUL J Director Exercise or conversion · Non Qualified Stock Option (Right to Buy) −20,000 0
2020-09-28 ANSTICE DAVID W Director Exercise or conversion +20,000 $14.92 $298K 86,213
2020-09-28 ANSTICE DAVID W Director Sale −17,832 $16.79 $299K 68,381
2020-09-28 ANSTICE DAVID W Director Exercise or conversion · Non Qualified Stock Option (Right to Buy) −20,000 0
2020-07-14 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Exercise or conversion +5,523 $18.11 $100K 207,345
2020-07-14 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Exercise or conversion · Employee Stock Option (Right to Buy) −5,523 94,477
2020-06-07 Hopkinson Craig C. EVP R&D, Chief Medical Officer Exercise or conversion +1,250 15,201
2020-06-07 Hopkinson Craig C. EVP R&D, Chief Medical Officer Shares withheld for taxes −368 $17.19 $6K 14,833
2020-06-07 Hopkinson Craig C. EVP R&D, Chief Medical Officer Exercise or conversion · Restricted Stock Unit Award −1,250 1,250
2020-06-05 Nichols Christian Todd SVP, Chief Commercial Officer Exercise or conversion +3,500 3,500
2020-06-05 Nichols Christian Todd SVP, Chief Commercial Officer Shares withheld for taxes −1,029 $17.19 $18K 2,471
2020-06-05 Nichols Christian Todd SVP, Chief Commercial Officer Exercise or conversion · Restricted Stock Unit Award −3,500 10,500
2020-06-05 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Gift −1,000 60,934

Page 71 of 75 · 1,492 trades